Our Company

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
NASDAQ: TNDM
Price:
$0.66
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:00 PM ET on Jul 19, 2017

View all »   RSSRecent Releases

Jul 13, 2017
Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release and Conference Call

Jun 12, 2017
Tandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial

View all »Events & Presentations

Jul 27, 2017 at 1:30 PM PT
Q2 Tandem Diabetes Care 2017 Earnings